BAILLIE GIFFORD & CO 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-02 09:38 am Sale | 2020-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS | BAILLIE GIFFORD & CO | 4,920,843 3.520% | -3,869,182 (-44.02%) | Filing |